| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
COO, Cd, Emea, Apac, Skin | COO, Eur., Apac, Afr Eur, Skin | Grp President, Eur& Developing Mkts +2 more
1 company
Panagiotis Tsourapas is COO, Cd, Emea, Apac, Skin at CL. Panagiotis Tsourapas's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.1M at current prices.
Our model assigns Panagiotis Tsourapas a middling insider score of 61/100, based on 13 past trades. Over a 12-month horizon, 45.5% of those trades were profitable, with an average 12-month return of -3.3%.
The CL filings lean toward selling, a net 407,441 shares.
Panagiotis Tsourapas has 44 Form 4 filings on record from September 2019 to September 2026, all as COO, Cd, Emea, Apac, Skin at Colgate-Palmolive (CL), 2019–2026.
The 82 reported transactions were 22 open-market sales, 21 tax withholdings, 20 option exercises and 10 stock awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 18 sales worth about $35.3M.
The largest open-market sale was 50,000 shares of CL at an average $95.57 on February 12, 2026, about $4.8M.
None of the 11 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 2026 | CL Colgate-Palmolive Company | COO, Cd, Emea, Apac, Skin | Sell | 10,000 | $92.05 | $920,477.00 | -13.4% | - | - | |
| Feb 12, 2026 | CL Colgate-Palmolive Company | COO, Eur., Apac, Afr Eur, Skin | Sale+OE | 50,000 | $95.57 | $4,778,436.50 | -82.8% | -8.6% | - | |
| Nov 4, 2024 | CL Colgate Palmolive Co | Grp President, Eur& Developing Mkts | Sell | 20,032 | $93.30 | $1,869,009.64 | -28.9% | -7.0% | -18.2% | |
| Aug 8, 2024 | CL Colgate Palmolive Co | Grp President, Eur& Developing Mkts | Sale+OE | 14,794 | $102.94 | $1,522,919.51 | -74.2% | -12.2% | -17.5% | |
| Jul 31, 2024 | CL Colgate Palmolive Co | Grp President, Eur& Developing Mkts | Sale+OE | 40,000 | $99.47 | $3,978,660.00 | -88.6% | -4.5% | -15.5% | |
| May 9, 2024 | CL Colgate Palmolive Co | Grp President, Eur& Developing Mkts | Sale+OE | 12,000 | $94.15 | $1,129,854.00 | -70.1% | +8.9% | -4.5% | |
| Jan 31, 2024 | CL Colgate Palmolive Co | Grp President, Eur& Developing Mkts | Sale+OE | 30,433 | $84.41 | $2,568,706.49 | -71.5% | +9.2% | +7.9% | |
| Nov 28, 2023 | CL Colgate Palmolive Co | Grp President, Eur& Developing Mkts | Sale+OE | 15,000 | $77.83 | $1,167,409.50 | -54.8% | +10.6% | +24.3% | |
| Nov 10, 2023 | CL Colgate Palmolive Co | Grp President, Eur& Developing Mkts | Sale+OE | 20,000 | $75.36 | $1,507,186.00 | -61.9% | +11.7% | +22.7% | |
| May 10, 2023 | CL Colgate Palmolive Co | Grp President, Eur& Developing Mkts | Sale+OE | 16,102 | $81.07 | $1,305,318.19 | -95.1% | -5.9% | +16.0% |